Paper32487993
Drug response analysis for scaffold-free cardiac constructs fabricated using bio-3D printer.
Arai K and 6 others. Sci Rep, 2020. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Drug response analysis for scaffold-free cardiac constructs fabricated using bio-3D printer. Papers, record 32487993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32487993
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Drug response analysis for scaffold-free cardiac constructs fabricated using bio-3D printer.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiotoxicity | Major topic |
| Drug Evaluation, Preclinical | Major topic |
| Induced Pluripotent Stem Cells | Major topic |
| Myocardial Contraction | Major topic |
| Myocytes, Cardiac | Major topic |
| Printing, Three-Dimensional | Major topic |
| Tissue Engineering | Major topic |
| Toxicity Tests | Major topic |
| Cell Survival | |
| Doxorubicin | |
| Heterocyclic Compounds, 4 or More Rings | |
| Humans | |
| Isoproterenol | |
| Propranolol | |
| Tissue Scaffolds |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20339370 | Human stem cells and drug screening: opportunities and challenges. | Nat Rev Drug Discov | 2010 | https://conductscience.org/library/papers/20339370 | PubMed |
| 2 | 21091654 | Principles of early drug discovery. | Br J Pharmacol | 2011 | https://conductscience.org/library/papers/21091654 | PubMed |
| 3 | 21574210 | Market withdrawal of new molecular entities approved in the United States from 1980 to 2009. | Pharmacoepidemiol Drug Saf | 2011 | https://conductscience.org/library/papers/21574210 | PubMed |
| 4 | 19442031 | Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates. | Expert Opin Drug Metab Toxicol | 2009 | https://conductscience.org/library/papers/19442031 | PubMed |
| 5 | 23507039 | Drug attrition during pre-clinical and clinical development: understanding and managing drug-induced cardiotoxicity. | Pharmacol Ther | 2013 | https://conductscience.org/library/papers/23507039 | PubMed |
| 6 | 25910965 | Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes. | J Pharmacol Toxicol Methods | 2015 | https://conductscience.org/library/papers/25910965 | PubMed |
| 7 | 27923051 | Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential. | PLoS One | 2016 | https://conductscience.org/library/papers/27923051 | PubMed |
| 8 | 28456566 | Assessment of acute and chronic toxicity of doxorubicin in human induced pluripotent stem cell-derived cardiomyocytes. | Toxicol In Vitro | 2017 | https://conductscience.org/library/papers/28456566 | PubMed |
| 9 | 24615475 | Measuring the contractile forces of human induced pluripotent stem cell-derived cardiomyocytes with arrays of microposts. | J Biomech Eng | 2014 | https://conductscience.org/library/papers/24615475 | PubMed |
| 10 | 17684528 | The third dimension bridges the gap between cell culture and live tissue. | Nat Rev Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17684528 | PubMed |
| 11 | 25985155 | Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation. | Biomaterials | 2015 | https://conductscience.org/library/papers/25985155 | PubMed |
| 12 | 18790825 | Myocardial tissue engineering. | Br Med Bull | 2008 | https://conductscience.org/library/papers/18790825 | PubMed |
| 13 | 29618819 | Advanced maturation of human cardiac tissue grown from pluripotent stem cells. | Nature | 2018 | https://conductscience.org/library/papers/29618819 | PubMed |
| 14 | 21741702 | Galactosylated cellulosic sponge for multi-well drug safety testing. | Biomaterials | 2011 | https://conductscience.org/library/papers/21741702 | PubMed |
| 15 | 27917703 | Principles of the Kenzan Method for Robotic Cell Spheroid-Based Three-Dimensional Bioprinting<sup/>. | Tissue Eng Part B Rev | 2017 | https://conductscience.org/library/papers/27917703 | PubMed |
| 16 | 26325298 | Scaffold-Free Tubular Tissues Created by a Bio-3D Printer Undergo Remodeling and Endothelialization when Implanted in Rat Aortae. | PLoS One | 2015 | https://conductscience.org/library/papers/26325298 | PubMed |
| 17 | 28192527 | The efficacy of a scaffold-free Bio 3D conduit developed from human fibroblasts on peripheral nerve regeneration in a rat sciatic nerve model. | PLoS One | 2017 | https://conductscience.org/library/papers/28192527 | PubMed |
| 18 | 29074999 | In vivo and ex vivo methods of growing a liver bud through tissue connection. | Sci Rep | 2017 | https://conductscience.org/library/papers/29074999 | PubMed |
| 19 | 29346562 | Scaffold-free trachea regeneration by tissue engineering with bio-3D printing. | Interact Cardiovasc Thorac Surg | 2018 | https://conductscience.org/library/papers/29346562 | PubMed |
| 20 | 29550580 | Regeneration of diaphragm with bio-3D cellular patch. | Biomaterials | 2018 | https://conductscience.org/library/papers/29550580 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42007256 | Biofabrication strategies for engineered constructs in cardiovascular tissue repair. | Regen Ther | 2026 | https://conductscience.org/library/papers/42007256 | PubMed |
| 41743838 | Biomimetic electrospun scaffolds for engineered heart tissue: from design parameters to drug testing platforms. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/41743838 | PubMed |
| 40697825 | Integrative approaches in cardiac tissue engineering: Bridging cellular complexity to create accurate physiological models. | iScience | 2025 | https://conductscience.org/library/papers/40697825 | PubMed |
| 39868032 | Bioprinting approaches in cardiac tissue engineering to reproduce blood-pumping heart function. | iScience | 2025 | https://conductscience.org/library/papers/39868032 | PubMed |
| 39715724 | Induction of cardiac alternans in human iPS-derived cardiomyocytes through β-adrenergic receptor stimulation. | Physiol Rep | 2024 | https://conductscience.org/library/papers/39715724 | PubMed |
| 39451329 | Bridging the Gap: Advances and Challenges in Heart Regeneration from In Vitro to In Vivo Applications. | Bioengineering (Basel) | 2024 | https://conductscience.org/library/papers/39451329 | PubMed |
| 38962658 | Progress of organoid platform in cardiovascular research. | Bioact Mater | 2024 | https://conductscience.org/library/papers/38962658 | PubMed |
| 38519491 | Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications. | Nat Commun | 2024 | https://conductscience.org/library/papers/38519491 | PubMed |
| 38041911 | A comprehensive review on 3D tissue models: Biofabrication technologies and preclinical applications. | Biomaterials | 2024 | https://conductscience.org/library/papers/38041911 | PubMed |
| 38006224 | Recent advances in soluble decellularized extracellular matrix for heart tissue engineering and organ modeling. | J Biomater Appl | 2023 | https://conductscience.org/library/papers/38006224 | PubMed |
| 37627245 | Three-Dimensional Bioprinting in Cardiovascular Disease: Current Status and Future Directions. | Biomolecules | 2023 | https://conductscience.org/library/papers/37627245 | PubMed |
| 37476002 | Rianú: Multi-tissue tracking software for increased throughput of engineered cardiac tissue screening. | Comput Methods Programs Biomed Update | 2023 | https://conductscience.org/library/papers/37476002 | PubMed |
| 36421097 | Advances in Cardiac Tissue Engineering. | Bioengineering (Basel) | 2022 | https://conductscience.org/library/papers/36421097 | PubMed |
| 35983280 | Validating the Arrhythmogenic Potential of High-, Intermediate-, and Low-Risk Drugs in a Human-Induced Pluripotent Stem Cell-Derived Cardiac Microphysiological System. | ACS Pharmacol Transl Sci | 2022 | https://conductscience.org/library/papers/35983280 | PubMed |
| 35957645 | A three-dimensional culture system for generating cardiac spheroids composed of cardiomyocytes, endothelial cells, smooth-muscle cells, and cardiac fibroblasts derived from human induced-pluripotent stem cells. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/35957645 | PubMed |
| 35592423 | Direct Contraction Force Measurements of Engineered Cardiac Tissue Constructs With Inotropic Drug Exposure. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35592423 | PubMed |
| 35563700 | Cell Aggregate Assembly through Microengineering for Functional Tissue Emergence. | Cells | 2022 | https://conductscience.org/library/papers/35563700 | PubMed |
| 35433691 | Human Engineered Heart Tissue Models for Disease Modeling and Drug Discovery. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35433691 | PubMed |
| 35247166 | A Change of Heart: Human Cardiac Tissue Engineering as a Platform for Drug Development. | Curr Cardiol Rep | 2022 | https://conductscience.org/library/papers/35247166 | PubMed |
| 35127867 | Scaffold-Free Tubular Engineered Heart Tissue From Human Induced Pluripotent Stem Cells Using Bio-3D Printing Technology in vivo. | Front Cardiovasc Med | 2021 | https://conductscience.org/library/papers/35127867 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PECAM1 | 5175 | PubTator's text mining | https://conductscience.org/library/genes/5175 | NCBI Gene |
| VIM | 7431 | PubTator's text mining | https://conductscience.org/library/genes/7431 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32487993
GET https://conductscience.org/api/papers/v1/32487993/references?page=2